U.S. Healthtech Stock News

KalVista Pharmaceuticals recently reported interim results from its KONFIDENT-KID trial, showing EKTERLY (sebetralstat) delivered rapid, well-tolerated oral treatment for hereditary angioedema attacks in children aged 2–11, with no serious or treatment-related adverse events. The trial, now the largest pediatric hereditary angioedema study and completed enrollment a year early, highlights strong clinical interest in a first-in-class oral option for a population currently limited to...

Recent performance snapshot Patterson-UTI Energy (PTEN) has drawn attention after a period of mixed share performance, with the stock showing a loss over the past week and month, but a strong gain in the past 3 months. See our latest analysis for Patterson-UTI Energy. At a share price of US$10.05, Patterson-UTI Energy has seen short term share price weakness, with a 7 day share price return of a 5.10% decline, set against a much stronger 90 day share price return of 40.56% and a 1 year total...

Ascendis Pharma (NasdaqGS:ASND) is back on investors’ radar after the release of new Week 52 data from its Phase 2 COACH trial and the granting of orphan drug exclusivity for its achondroplasia therapy YUVIWEL in the U.S. See our latest analysis for Ascendis Pharma. The latest COACH trial readout and YUVIWEL orphan exclusivity news arrive as Ascendis Pharma’s share price sits at US$239.28, with a 90 day share price return of 11.27% and a 1 year total shareholder return of 53.88%. This...

AAON (AAON) shares have been gaining attention after the company introduced liquid cooling solutions for AI focused data centers, coinciding with improved sentiment toward industrial names as geopolitical tensions ease. See our latest analysis for AAON. The recent AI focused product launch and easing geopolitical tensions have arrived against a backdrop of firm momentum, with a 7 day share price return of 14.67% and a 17.65% year to date share price return. The 5 year total shareholder return...

Ares Management (NYSE:ARES) agreed to acquire Whitestone REIT in a transaction valued at about US$1.7b, taking the retail-focused real estate trust private. The deal expands Ares' exposure to necessity-based retail centers in fast-growing U.S. metro areas. Alongside the acquisition, Ares announced leadership changes in its Asia business, including E.G. Morse as Partner and Head of Asia Credit. Dinesh Goel and Gabriel Fong were elevated to lead Asia Special Situations, reshaping Ares' senior...

In recent months, Magnolia Oil & Gas reported quarterly results that slightly trailed the prior year on revenue but surpassed analyst expectations on both revenue and earnings per share, while management emphasized a capital-efficient model and high-quality Eagle Ford and Austin Chalk assets. This combination of outperformance versus forecasts, ongoing capital discipline, and a focus on free cash flow has shaped investor perception more than short-term oil price swings or mixed analyst...

Recent share performance and business snapshot Hamilton Lane (HLNE) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date and over the past year. At a last close of US$92.28, Hamilton Lane has a market value of about US$5.19b, generates revenue of US$763.4m and net income of US$233.5m, and holds a reported value score of 3. See our latest analysis for Hamilton Lane. Hamilton Lane's...

Recent developments at Citizens Financial Group include renewed analyst optimism ahead of its upcoming earnings report, alongside a substantial increase in institutional ownership by Altfest L J & Co. Inc., which more than doubled its stake in the bank in the fourth quarter. Together, the upbeat earnings expectations and expanded institutional interest highlight how professional investors are responding to Citizens’ evolving business mix and operational initiatives. With institutional...

Why Oshkosh’s recent valuation and insider moves matter now Oshkosh (OSK) has drawn fresh attention after trading well above an estimated intrinsic value, while insiders sold roughly $0.9 million of stock over the past 3 months without any reported purchases. See our latest analysis for Oshkosh. At a share price of US$151.79, Oshkosh has seen a 14.8% year to date share price return and a 78.9% total shareholder return over the past year. This suggests strong momentum even after a recent 3.1%...

In early April 2026, Applied Optoelectronics announced it had received an additional US$71 million order for 800G single-mode data center transceivers from a major hyperscale customer, lifting this customer’s total 800G orders since mid-March to US$124 million and more than doubling the prior backlog. This upsized order, with deliveries scheduled to begin in the second quarter and run through year-end, highlights how rapidly AI-related data traffic is translating into concrete,...

In the most recent quarter, G-III Apparel Group reported revenue growth versus the prior year and earnings per share that exceeded analyst estimates, even as GAAP earnings per share declined. This mix of top-line progress and an earnings beat, alongside analyst expectations for further growth, highlights how the company is balancing expansion with profitability pressures. With revenue rising and earnings per share topping forecasts, we’ll now examine how this earnings report reshapes...

Why TeraWulf’s pivot is back in focus TeraWulf (WULF) is drawing fresh attention after shifting its business from bitcoin mining to high density compute infrastructure, supported by new agreements with Core42 and Fluidstack that align the company more directly with AI focused data center demand. See our latest analysis for TeraWulf. The recent deals with Core42 and Fluidstack come as TeraWulf’s 7 day share price return of 21.35% and 30 day share price return of 28.63% keep momentum strong,...

ImmunityBio recently reported preliminary first-quarter 2026 net product revenue of about US$44.2 million, an approximately 168% year-over-year increase, alongside continued international rollout of its bladder cancer therapy ANKTIVA across roughly 34 countries. At the same time, the company is working through FDA promotional compliance issues and related securities class actions, while emphasizing corrective measures and stronger internal controls around how ANKTIVA’s benefits are...

Rising fuel costs and what they could mean for FirstCash Holdings (FCFS) Rising fuel costs are starting to influence how consumers use pawn services, with operators across the US reporting higher loan demand, more high-value collateral and borrowers requesting extra time to repay existing loans. See our latest analysis for FirstCash Holdings. FirstCash Holdings’ recent share price strength, including a 21.57% 3 month share price return and 28.61% year to date share price return to $201.63,...

On April 8, 2026, Life Time Inc. fully opened Life Time Eagle, its first 135,000-square-foot athletic country club in Idaho, adding one of the Treasure Valley’s largest recent wellness developments and employing more than 200 people. This expansion extends Life Time’s nearly 190-club North American network into the Boise area, highlighting its focus on comprehensive, premium wellness experiences that integrate fitness, recovery, family amenities and social spaces. We’ll now explore how...

Cincinnati Financial has already released its first-quarter 2026 results, following an earlier announcement that it would report after the market close on April 27 and host a webcast the next day to discuss performance. Investor attention has centered on analysts’ expectations for a strong rebound in profitability and management’s comments on catastrophe exposure, reserves, and premium growth amid sector headwinds. With optimism around first-quarter profit recovery and guidance, we’ll...

The recent reopening of the Strait of Hormuz under a temporary ceasefire eased shipping disruptions, reducing detours and improving fuel efficiency for global freight flows. For Douglas Dynamics, a manufacturer of commercial work truck attachments and equipment, this improvement in logistics conditions has supported sentiment without materially changing the company’s underlying business outlook. Now we’ll examine how easing freight bottlenecks and improved logistics conditions may influence...

The key story for Axsome Therapeutics (AXSM) right now is the looming US Food and Drug Administration decision on Auvelity for Alzheimer’s related agitation, a potential catalyst that investors are watching closely. See our latest analysis for Axsome Therapeutics. Those expectations seem to be feeding into the share price, with Axsome’s 1 month share price return of 14.11% and 1 year total shareholder return of 72.04% pointing to building momentum, despite relatively muted moves over the past...

In recent days, LCI Industries has attracted fresh attention as analysts raised full-year earnings estimates and assigned favorable rankings, while institutional and AI-driven trading models highlighted the stock’s perceived risk‑reward appeal across multiple timeframes. At the same time, the company’s push to diversify beyond its core RV components business through acquisitions and aftermarket expansion has reinforced the view that its operations may be more resilient than current market...

Mphasis recently announced it had completed a major technology modernization program for Flagstar Bank, N.A., consolidating six legacy data centers into two next-generation facilities and migrating hundreds of critical applications with zero downtime, significantly enhancing the bank’s resilience and cloud-enabled infrastructure. This large-scale upgrade gives Flagstar a more scalable and flexible technology backbone that can support faster product rollout, operational efficiency gains, and...

Wondering whether Rayonier's current share price reflects its true value, or if the market is mispricing this timber and land-focused REIT? This article sets out the key facts so you can judge for yourself. Rayonier's shares last closed at US$21.20, with a 2.0% return over the past week and 5.1% over the past month, while year to date the stock shows a 1.9% decline and a 5.6% decline over the past year. Recent news coverage has mainly centered on Rayonier's positioning within the Specialized...

Earlier this month, Five Below reported quarterly revenue of US$1.73 billion, about 1.1% above analyst expectations, alongside stronger‑than‑expected earnings and upbeat guidance that management linked to effective execution of its customer‑focused growth strategy. At the same time, the retailer has been expanding its footprint and seasonal assortment, from new store openings to fresh low‑priced spring and pet products, underscoring how its value formula is being applied across more...

Asbury Automotive Group (ABG) is drawing fresh investor attention after celebrating the grand opening of its renovated Dealership Support Center in Sandy Springs, a project tied to 350 new local jobs. See our latest analysis for Asbury Automotive Group. The grand opening comes as Asbury’s recent share price performance has been mixed, with a 7 day share price return of 4.40% contrasting with a 90 day share price return decline of 16.91% and a 1 year total shareholder return of 9.53% in the...

Johnson & Johnson (JNJ) is back in focus after recent trading, giving investors a fresh chance to assess how this US$574.4b healthcare giant fits into their portfolios at a share price of US$238.46. See our latest analysis for Johnson & Johnson. Recent trading has been slightly soft, with a 30 day share price return of 1.27% compared with a stronger 90 day share price return of 11.61%. The 1 year total shareholder return of 58.79% points to momentum that has built over a longer horizon. If...